RNA sequencing reveals upregulation of RUNX1-RUNX1T1 gene signatures in clear cell renal cell carcinoma

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Xiong, Zuquan ^a   Yu, Hongjie ^b   Ding, Yan ^c   Feng, Chenchen ^a   Wei, Hanming ^b   Tao, Sha ^d   Huang, Dan ^c   Zheng, Siqun Lilly ^d   Sun, Jielin ^d   Xu, Jianfeng ^a,b,d   Fang, Zujun ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c VAN ANDEL RESEARCH INSTITUTE   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX1T1; TRANSCRIPTOME; UNCLASSIFIED DRUG; ONCOPROTEIN; RNA; RUNX1 PROTEIN, HUMAN; RUNX1T1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; RNA SEQUENCE; TUMOR GENE; UPREGULATION; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; MIDDLE AGED; MOLECULAR GENETICS; SEQUENCE ANALYSIS;

ADULT; AGED; BASE SEQUENCE; CARCINOMA, RENAL CELL; CORE BINDING FACTOR ALPHA 2 SUBUNIT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS; RNA; SEQUENCE ANALYSIS, RNA; TRANSCRIPTION FACTORS; TRANSCRIPTOME; UP-REGULATION;

EID: 84899547426     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/450621     Document Type: Article

References (32)

1. Siegel R., Naishadham D., Jemal A., Cancer statistics, 2012. CA Cancer Journal for Clinicians 2012 62 1 10 29 2-s2.0-84855792427 10.3322/caac.20138
2. Cohen H. T., McGovern F. J., Renal-cell carcinoma. The New England Journal of Medicine 2005 353 23 2477 2490 2-s2.0-28844484134 10.1056/NEJMra043172 (Pubitemid 41770167)
3. Takahashi M., Yang X. J., Sugimura J., Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 2003 22 6810 6818 10.1038/sj.onc.1206869 (Pubitemid 37372221)
4. Furge K. A., Lucas K. A., Takahashi M., Sugimura J., Kort E. J., Kanayama H.-O., Kagawa S., Hoekstra P., Curry J., Yang X. J., Teh B. T., Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles. Cancer Research 2004 64 12 4117 4121 2-s2.0-3042667856 10.1158/0008-5472.CAN-04-0534 (Pubitemid 38802413)
5. Furge K. A., Chen J., Koeman J., Swiatek P., Dykema K., Lucin K., Kahnoski R., Yang X. J., Bin T. T., Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma. Cancer Research 2007 67 7 3171 3176 2-s2.0-34248168006 10.1158/0008-5472.CAN-06-4571 (Pubitemid 46724854)
6. Ding Y., Huang D., Zhang Z., Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets. Cancer Research 2011 71 5225 5234 10.1158/0008-5472.CAN-11-0076
7. Sultan M., Schulz M. H., Richard H., A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 2008 321 956 960 10.1126/science.1160342
8. Chepelev I., Wei G., Tang Q., Zhao K., Detection of single nucleotide variations in expressed exons of the human genome using RNA-Seq. Nucleic Acids Research 2009 37 16 e106 2-s2.0-70449721097 10.1093/nar/gkp507
9. Mortazavi A., Williams B. A., McCue K., Schaeffer L., Wold B., Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nature Methods 2008 5 7 621 628 2-s2.0-46249106990 10.1038/nmeth.1226 (Pubitemid 351911867)
10. Greif P. A., Eck S. H., Konstandin N. P., Benet-Pagès A., Ksienzyk B., Dufour A., Vetter A. T., Popp H. D., Lorenz-Depiereux B., Meitinger T., Bohlander S. K., Strom T. M., Identification of recurring tumor-specific somatic mutations in acute myeloid leukemia by transcriptome sequencing. Leukemia 2011 25 5 821 827 2-s2.0-79955854144 10.1038/leu.2011.19
11. Grant G. R., Farkas M. H., Pizarro A. D., Lahens N. F., Schug J., Brunk B. P., Stoeckert C. J., Hogenesch J. B., Pierce E. A., Comparative analysis of RNA-Seq alignment algorithms and the RNA-Seq unified mapper (RUM). Bioinformatics 2011 27 18 2518 2528 2-s2.0-80052745094 10.1093/bioinformatics/ btr427 btr427
12. Langmead B., Trapnell C., Pop M., Salzberg S. L., Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biology 2009 10 3, article R25 2-s2.0-62349130698 10.1186/gb-2009-10-3-r25
13. Li H., Handsaker B., Wysoker A., The sequence alignment/map format and SAMtools. Bioinformatics 2009 25 2078 2079 10.1093/bioinformatics/btp352
14. Garber M., Grabherr M. G., Guttman M., Trapnell C., Computational methods for transcriptome annotation and quantification using RNA-seq. Nature Methods 2011 8 6 469 477 2-s2.0-79957842166 10.1038/nmeth.1613
15. Anders S., Huber W., Differential expression analysis for sequence count data. Genome Biology 2010 11 10, article R106 2-s2.0-77958471357 10.1186/gb-2010-11-10-r106
16. Furge K. A., Dykema K. J., Ho C., Chen X., Comparison of array-based comparative genomic hybridization with gene expression-based regional expression biases to identify genetic abnormalities in hepatocellular carcinoma. BMC Genomics 2005 6, article 67 2-s2.0-25444471841 10.1186/1471-2164-6-67 (Pubitemid 41357668)
17. Klomp J. A., Petillo D., Niemi N. M., Birt-Hogg-Dube renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression. BMC Med Genomics 3, article 59 10.1186/1755-8794-3-59
18. MacKeigan J. P., Murphy L. O., Blenis J., Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nature Cell Biology 2005 7 6 591 600 2-s2.0-20444419344 10.1038/ncb1258 (Pubitemid 40796982)
19. Lopez-Jimenez E., Gómez-López G., Leandro-García L. J., Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas. Molecular Endocrinology 2010 24 12 2382 2391 10.1210/me.2010-0256
20. Aprelikova O., Chandramouli G. V. R., Wood M., Vasselli J. R., Riss J., Maranchie J. K., Linehan W. M., Barrett J. C., Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. Journal of Cellular Biochemistry 2004 92 3 491 501 2-s2.0-4644237401 10.1002/jcb.20067
21. Grabmaier K., Vissers J. L., de Weijert M. C., Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250. International Journal of Cancer 2000 85 865 870 (Pubitemid 30131479)
22. Oosterwijk E., Ruiter D. J., Hoedemaeker J., Monoclonal antibody G250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. International Journal of Cancer 1986 38 4 489 494 2-s2.0-0022502868 (Pubitemid 16006918)
23. Siemeister G., Weindel K., Mohrs K., Barleon B., Martiny-Baron G., Marmé D., Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Research 1996 56 10 2299 2301 2-s2.0-0029920054 (Pubitemid 26154077)
24. Iliopoulos O., Levy A. P., Jiang C., Kaelin W. G. Jr., Goldberg M. A., Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proceedings of the National Academy of Sciences of the United States of America 1996 93 20 10595 10599 2-s2.0-0029785321 10.1073/pnas.93.20.10595 (Pubitemid 26333032)
25. Giebisch G., Renal potassium transport: Mechanisms and regulation. The American Journal of Physiology-Renal Physiology 1998 274 5 F817 F833 2-s2.0-0031831767
26. Kort E. J., Farber L., Tretiakova M., Petillo D., Furge K. A., Yang X. J., Cornelius A., Bin T. T., The E2F3-oncomir-1 axis is activated in Wilms' tumor. Cancer Research 2008 68 11 4034 4038 2-s2.0-49249108314 10.1158/0008-5472.CAN-08-0592
27. Tonks A., Pearn L., Musson M., Gilkes A., Mills K. I., Burnett A. K., Darley R. L., Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia. Leukemia 2007 21 12 2495 2505 2-s2.0-36349010744 10.1038/sj.leu.2404961 (Pubitemid 350148893)
28. Peterson L. F., Zhang D. E., The 8;21 translocation in leukemogenesis. Oncogene 2004 23 24 4255 4262 2-s2.0-2942516037 10.1038/sj.onc.1207727 (Pubitemid 38758592)
29. Yagoda A., Abi-Rached B., Petrylak D., Chemotherapy for advanced renal-cell carcinoma: 1983-1993. Seminars in Oncology 1995 22 1 42 60 2-s2.0-0028928749
30. Fojo A. T., Shen D.-W., Mickley L. A., Pastan I., Gottesman M. M., Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene. Journal of Clinical Oncology 1987 5 12 1922 1927 2-s2.0-0023499815 (Pubitemid 18010151)
31. Guimaraes D. P., Oliveira I. M., de Moraes E., Interferon-inducible guanylate binding protein (GBP)-2: a novel p53-regulated tumor marker in esophageal squamous cell carcinomas. International Journal of Cancer 2009 124 2 272 279 10.1002/ijc.23944
32. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013 499 7456 43 49 10.1038/nature12222